PropertyValue
?:abstract
  • COVID-19 is a distinctive infection characterized by elevated inter-human transmission and presenting from absence of symptoms to severe cytokine storm that can lead to dismal prognosis. Like for HIV, lymphopenia and drastic reduction of CD4+ T cell counts in COVID-19 patients have been linked with poor clinical outcome. As CD4+ T cells play a critical role in orchestrating responses against viral infections, important lessons can be drawn by comparing T cell response in COVID-19 and in HIV infection and by studying HIV-infected patients who became infected by SARS-CoV-2. We critically reviewed host characteristics and hyper-inflammatory response in these two viral infections to have a better insight on the large difference in clinical outcome in persons being infected by SARS-CoV-2. The better understanding of mechanism of T cell dysfunction will contribute to the development of targeted therapy against severe COVID-19 and will help to rationally design vaccine involving T cell response for the long-term control of viral infection.
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2020.596631
?:journal
  • Front_Immunol
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/ee2b7e2df161f2d65267f51165ddcffbeb18c322.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7770166.xml.json
?:pmcid
?:pmid
?:pmid
  • 33384690.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
?:type
?:year
  • 2020-12-15

Metadata

Anon_0  
expand all